Junrui Lin
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
-
- IL-33, ST2, and ILC Pathways 2
- Immune Cell Function and Interaction 2
- Mast cells and histamine 1
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Joshua A. Boyce (5 shared papers)Jun Nagai (4 shared papers)Timothy Kyin (2 shared papers)Edy Yong Kim (1 shared paper)Marco Idzko (1 shared paper)Patrick J. Brennan (2 shared papers)Barbara Balestrieri (3 shared papers)Laura B. Fanning (2 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (2 papers)Cell (2 papers)Cell Reports (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesAustriaJapan
In The Last Decade
Junrui Lin
8 papers receiving 302 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 222
- Modeling and Simulation 18
- Physiology 14
- Immunology 59
- Animal Science and Zoology 25
Countries citing papers authored by Junrui Lin
This map shows the geographic impact of Junrui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junrui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junrui Lin more than expected).
Fields of papers citing papers by Junrui Lin
This network shows the impact of papers produced by Junrui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junrui Lin. The network helps show where Junrui Lin may publish in the future.
Co-authors
The 15 scholars most cited alongside Junrui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 142 | |
| 2 | 2021 | 89 | |
| 3 | 2021 | 31 | |
| 4 | 2019 | 25 | |
| 5 | 2022 | 9 | |
| 6 | 2007 | 6 | |
| 7 | 2019 | 1 | |
| 8 | 2026 | 1 | |
| 9 | 2025 | 0 |
About Junrui Lin
Junrui Lin is a scholar working on Immunology, Infectious Diseases, Physiology, Emergency Medical Services and Biotechnology, having authored 9 papers that have together received 304 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Asthma and respiratory diseases (2 papers), Immune Cell Function and Interaction (2 papers), Mast cells and histamine (1 paper), Transgenic Plants and Applications (1 paper) and Long-Term Effects of COVID-19 (1 paper). The work is most often cited by research in Infectious Diseases (222 citations), Modeling and Simulation (18 citations), Physiology (14 citations), Immunology (59 citations) and Animal Science and Zoology (25 citations). Junrui Lin has collaborated with scholars based in United States, Austria and Japan. Frequent co-authors include Joshua A. Boyce, Jun Nagai, Timothy Kyin, Edy Yong Kim, Marco Idzko, Patrick J. Brennan, Barbara Balestrieri, Laura B. Fanning, Andreas Zech and Asuka Inoue. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Cell, Cell Reports, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.